Clinical trial
Development of a Molecular Diagnosing Platform for Monitoring Oral Hygiene in Diabetic Patients
NCT03351530 is registered in ClinicalTrials.gov with General Biologicals Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Molecular Diagnosing Platform for Monitoring Oral Hygiene in Diabetic Patients
- Lead sponsor
- General Biologicals Corporation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 18, 2017
- Completion date
- February 9, 2019
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.